Authors' Reply
- PMID: 26216006
- PMCID: PMC6711084
- DOI: 10.1002/clc.22413
Authors' Reply
Comment on
-
Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot study.Clin Cardiol. 2015 Feb;38(2):92-8. doi: 10.1002/clc.22357. Epub 2015 Feb 5. Clin Cardiol. 2015. PMID: 25655085 Free PMC article.
-
Platelet Function Testing and Prediction of Bleeding in Patients Exposed to Clopidogrel Undergoing Coronary Artery Surgery.Clin Cardiol. 2015 Jul;38(7):443-4. doi: 10.1002/clc.22414. Epub 2015 May 22. Clin Cardiol. 2015. PMID: 25998754 Free PMC article. No abstract available.
References
-
- Reed GW, Guo J, Hoffman EB, et al. Aspirin responsiveness testing predicts bleeding during coronary artery bypass grafting: the Verify Pre‐Op–TIMI 45 study. Circulation. 2013;128:A10331.
-
- Petricevic M, Biocina B, Milicic D, et al. Bleeding risk assessment using multiple electrode aggregometry in patients following coronary artery bypass surgery. J Thromb Thrombolysis. 2013;35:31–40. - PubMed
-
- Rosengart TK, Romeiser JL, White JK, et al. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration. J Thorac Cardiovasc Surg. 2013;146:1259–1266. - PubMed
-
- Alstrom U, Granath F, Oldgren J, et al. Platelet inhibition assessed with verifynow, flow cytometry, and platelet mapping in patients undergoing heart surgery. Thromb Res. 2009;124:572–577. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
